Close Menu

More articles about Research & Discovery

Subscribers: click headline for more.

Subscribers: click headline for more.

Researchers from big pharma, academia, and proteomics equipment suppliers at last week s ACI (Active Communications International) proteomics meeting in Boston, chaired by Steven Naylor, chief technology officer at Beyond Genomics, got a look at a broad sampling of the various approaches to applying proteomics to drug discovery. Subscribers: click headline for more.

MDS Sciex plans to use $5.6 million awarded this month by Genome Canada, an arm of the Canadian government with a mandate to stimulate genomics and proteomics research, to expand its R&D collaborations with Canadian universities in the areas of MALDI-TOF mass spectrometer development and sample handling and preparation, Sciex president Andy Boorn told ProteoMonitor. Subscribers: click headline for more.

While proteomics has been the darling of private investors for several years, governments in the US and in Europe are now getting ready to open their checkbooks to large-scale proteomics research as well. Subscribers: click headline for more.

When a coalition of US and European scientists published the first draft of the human genome in Nature last year, the announcement left scientists elsewhere in the world feeling slightly left out. Subscribers: click headline for more.

. Subscribers: click headline for more.

. Subscribers: click headline for more.

. Subscribers: click headline for more.

. Subscribers: click headline for more.

Subscribers: click headline for more.

Brian Chait, Timothy Alavosus

Premium

Subscribers: click headline for more.

Taking advantage of the Canadian government s multihundred million dollar program to foster the country s biotech research capabilities, Affinium Pharmaceuticals, ne Integrative Proteomics, said last week that it had received $7 million from Genome Canada and the Ontario Genomics Institute to study viral proteins. Subscribers: click headline for more.

Everyone knows that 2D gels are a difficult and labor-intensive way to separate proteins. Subscribers: click headline for more.

Subscribers: click headline for more.

Subscribers: click headline for more.

SurroMed has formed a new company, Nanoplex Technologies, to develop applications for its submicrometer barcoding technology in proteomics and other fields, ProteoMonitor learned last week Subscribers: click headline for more.

In an illustration of how techniques for studying the proteome are finding an increasingly wide array of potential applications in drug discovery, AstraZeneca last week agreed to work with Ambit Biosciences to use the company s phage display and affinity chromatography technology to identify proteins that interact with specific small molecules Subscribers: click headline for more.

Subscribers: click headline for more.

Subscribers: click headline for more.

Pages

Los Angeles brought and settled a civil enforcement action against the makers of an at-home test for SARS-CoV-2, NPR reports. 

The Guardian reports that Cancer Research UK is cutting its research funding by £44 million.

Technology Review examines factors affecting SARS-CoV-2 testing turnaround times.

In PNAS this week: mapping of ancient human migrations in Europe, recurrent gene fusion in breast cancer, and more.